Talis Biomedical Corporation (TLIS)

Talis Biomedical Analyst Ratings

• Total Analysts: 1
• Consensus Rating: Strong Sell
• Price Target: $5.00
• Upside: -41.18%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mark Massaro BTIG	BTIG	Strong Sell Maintains $0.35 → $5	Strong Sell	Maintains	$0.35 → $5	-41.18%	Aug 16, 2023
Mark Massaro BTIG	BTIG	Hold → Strong Sell Downgrades $15	Hold → Strong Sell	Downgrades	$15	+76.47%	Mar 18, 2022
Derik De Bruin B of A Securities	B of A Securities	Sell Maintains $45 → $23	Sell	Maintains	$45 → $23	+164.71%	Mar 16, 2022
Derik De Bruin B of A Securities	B of A Securities	Hold → Sell Downgrades $45	Hold → Sell	Downgrades	$45	+429.41%	Jan 7, 2022
Tycho Peterson JP Morgan	JP Morgan	Hold → Sell Downgrades $150 → $105	Hold → Sell	Downgrades	$150 → $105	+1,135.29%	Sep 27, 2021
Steven Mah Piper Sandler	Piper Sandler	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Aug 12, 2021
Tycho Peterson JP Morgan	JP Morgan	Buy → Hold Downgrades $255 → $150	Buy → Hold	Downgrades	$255 → $150	+1,664.71%	Aug 11, 2021
Mark Massaro BTIG	BTIG	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Mar 9, 2021
Tycho Peterson JP Morgan	JP Morgan	Buy Initiates $270	Buy	Initiates	$270	+3,076.47%	Mar 9, 2021
Derik De Bruin B of A Securities	B of A Securities	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Mar 9, 2021
Steven Mah Piper Sandler	Piper Sandler	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Mar 9, 2021